This study provides comprehensive computational evidence that berberine exerts anti-hepatocellular carcinoma effects through dual targeting of AURKA and CDK1, two critical cell cycle regulators frequently overexpressed in hepatocellular carcinoma. The gene discussed is CDK1; the disease is hepatocellular carcinoma.